Davidson Kempner Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-5,473,378
| Closed | -$1.01B | – | 647 |
|
|
2021
Q2 | $1.01B | Buy |
5,473,378
+1,409,202
| +35% | +$259M | 7.81% | 1 |
|
|
2021
Q1 | $621M | Buy |
4,064,176
+3,444,997
| +556% | +$526M | 6.18% | 1 |
|
|
2020
Q4 | $96.7M | Buy |
+619,179
| New | +$96.7M | 1.13% | 20 |
|
|
2017
Q2 | – | Sell |
-338,474
| Closed | -$41M | – | 191 |
|
|
2017
Q1 | $41M | Buy |
338,474
+272,508
| +413% | +$33M | 0.47% | 30 |
|
|
2016
Q4 | $8.07M | Buy |
+65,966
| New | +$8.07M | 0.16% | 106 |
|
|
2015
Q3 | – | Sell |
-432,378
| Closed | -$78.1M | – | 195 |
|
|
2015
Q2 | $78.1M | Buy |
+432,378
| New | +$78.1M | 1.28% | 12 |
|
|
2013
Q4 | – | Sell |
-10,000
| Closed | -$1.16M | – | 158 |
|
|
2013
Q3 | $1.16M | Buy |
+10,000
| New | +$1.16M | 0.04% | 112 |
|